What does MindWalk's new patent cover?

The patent application EP26187897.9 covers high-dimensional data structures for biological subsequences and property inference, protecting the enriched biological representation architecture that underpins HYFT® Technology, ReefIQ™, and LensAI™. It protects a distinct computational layer that organizes biological meaning around characteristic patterns into a form that can be reused across MindWalk's infrastructure and customer programs.

What is the market opportunity for AI in drug discovery?

Spending on AI in drug discovery is projected to grow from approximately US$5 billion（約8000億円） in 2026 to more than US$8 billion（約1.3兆円） by 2030, and it sits atop the more than US$250 billion（約40兆円） the pharmaceutical industry invests in research and development each year.

How does this filing differ from MindWalk's earlier patent?

The new application builds on MindWalk's foundational HYFT patent (EP3881326A1), which established how the company identifies characteristic biological patterns and uses them as a searchable language. The new filing protects a distinct and additive layer—the computational layer built on that original foundation—rather than a re-filing.

AI in HealthcareAI Business & IndustryYahoo Finance AIJul 1, 2026Jul 1, 2026, 22:00 JST

MindWalk Files Patent for AI Drug Discovery Data Layer

Send on LINE

3 Key Points

What happened
MindWalk Holdings (NASDAQ: HYFT) announced the filing of European patent application EP26187897.9, which covers high-dimensional data structures for biological subsequences and property inference. The patent is intended to protect the enriched biological representation architecture that underpins MindWalk's HYFT® Technology, ReefIQ™ biological context layer, and LensAI™ reasoning workflows.
Why it matters
As AI models become more widely available, the company believes lasting advantage in life sciences will come from the data layer—the structured, domain-specific biological representation that lets models and AI agents retrieve, compare, and reason over biology with traceable context. Spending on AI in drug discovery is projected to grow from approximately US$5 billion（約8000億円） in 2026 to more than US$8 billion（約1.3兆円） by 2030, sitting atop the more than US$250 billion（約40兆円） the pharmaceutical industry invests in research and development each year.
What to watch
The new filing builds on MindWalk's foundational HYFT patent (EP3881326A1) and protects a distinct computational layer—organizing biological meaning around characteristic patterns into a form that can be reused across MindWalk's infrastructure, customer programs, and AI workflows. Recent public work on scientific agents, including NVIDIA's BioNeMo Agent Toolkit and AstraZeneca's ChatInvent system, points to the need for domain-specific context, structured tool interfaces, and reliable input/output schemas when AI agents are deployed in real scientific workflows.

Not sure about something? Ask the AI

Questions and answers are published on this page.

Summaries like this, in your inbox every morning.

Get news like this every morning, free

FAQ

What does MindWalk's new patent cover?: The patent application EP26187897.9 covers high-dimensional data structures for biological subsequences and property inference, protecting the enriched biological representation architecture that underpins HYFT® Technology, ReefIQ™, and LensAI™. It protects a distinct computational layer that organizes biological meaning around characteristic patterns into a form that can be reused across MindWalk's infrastructure and customer programs.
What is the market opportunity for AI in drug discovery?: Spending on AI in drug discovery is projected to grow from approximately US$5 billion（約8000億円） in 2026 to more than US$8 billion（約1.3兆円） by 2030, and it sits atop the more than US$250 billion（約40兆円） the pharmaceutical industry invests in research and development each year.
How does this filing differ from MindWalk's earlier patent?: The new application builds on MindWalk's foundational HYFT patent (EP3881326A1), which established how the company identifies characteristic biological patterns and uses them as a searchable language. The new filing protects a distinct and additive layer—the computational layer built on that original foundation—rather than a re-filing.

Yahoo Finance AIRead Original Article

Send on LINE

AI news that matters for your work, delivered every morning.

Pick your industry and the AI tools you use, and get news related to your work every day.

Get it free

Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →

Ask AI

Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.